Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 187 BEAM shares, $4.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 187 | $4.6K |
| Apr 6, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 3,242 | $79.7K |
| Apr 2, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 20,000 | n/a |
| Feb 2, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 40,000 | n/a |
| Jan 26, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 6,198 | $216.9K |
| Jan 21, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 3,034 | $91.4K |
| Oct 3, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 467 | $11.5K |
| Apr 4, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 3,015 | $55.3K |
| Apr 2, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 10,000 | n/a |
| Feb 20, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 6,287 | $220.0K |